author-photo

O. Purcaru

UCB

54

Papers

474

Citations

Citation Trend

Filter By

Papers (42) Sort By

Journal Conference Others

Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III study

2018 RMD Open
Show All
- Source
- Cite
- Save
Citations (4)
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study

2017 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (58)
Response to: ‘Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!’ by Boers

2016 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Improvements in Productivity at Paid Work and Within the Household, and Increased Participation in Daily Activities Over 52 Weeks of Certolizumab Pegol Treatment of Rheumatoid Arthritis: Results of A Belgian Observational Non-Interventional Study

2016 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
SAT0389 Long-Term Improvements in Workplace and Household Productivity and Social Participation over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

2016 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (2)
Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis, with and without Prior Anti-Tnf Exposure

2016 Value in Health
Show All
- Source
- Cite
- Save
Citations (1)
PMS82 – Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol

2016 Value in Health
Show All
- Source
- Cite
- Save
Citations (1)
Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

2016 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
THU0128 Maintenance of Improvements in Workplace and Household Productivity and Physical Function at 2 Years in Early RA Patients with Severe Progressive Disease Who Achieved Sustained Low Disease Activity Following 1 Year of Initial Therapy, with Two Dosing Frequencies of Certolizumab Pegol

2016 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

2015 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (84)